Strategy of “Controllable Ions Interference” for Boosting MRI-Guided Ferroptosis Therapy of Tumors
Authors:
- 13 February 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (8) , 11688-11703
Abstract
Chemotherapy for oral squamous cell carcinoma (OSCC) is often marred by the development of multidrug resistance and systemic adverse effects. Metal ion interference therapy (MIIT) has risen as an innovative strategy to disrupt the intracellular metal ion equilibrium in tumor cells, potentially overcoming drug resistance. However, the effectiveness of cancer treatment that relies on delivering single metal ions to tumor site is often constrained. To address this, we have developed a therapeutic nanoplatform employing hollow mesoporous manganese dioxide nanoparticles (HMON) which harness the chelating properties of tannic acid to control the loading and release of Zn2+ and Pt2+, i.e., Zn@CDDP@HMON. In acidic tumor microenvironment, Zn2+ and Pt2+ ions strategically released from nanoplatform can inhibit mitochondrial respiration and activate NADPH oxidases (NOXs), respectively, increasing superoxide anion (O2•-) and hydrogen peroxide production (H2O2). The released Mn4+ consumes intracellular glutathione (GSH) to generate Mn2+, which reacts with H2O2 in a Fenton-like reaction, producing hydroxyl radicals (•OH) and inducing lipid peroxidation (LPO). The depletion of GSH also inhibits GPX4 activity, sensitizing tumor cells to ferroptosis. Furthermore, the reduced Mn2+ facilitates T1-MRI imaging, allowing for real-time monitoring of nanoplatform distribution and accumulation in tumors.Keywords
Funding Information
- Guangzhou Medical University (2024SRP139)
This publication has 46 references indexed in Scilit:
- Engineered‐Doping Strategy for Self‐Sufficient Reactive Oxygen Species Blossom to Amplify Ferroptosis/Cuproptosis Sensibilization in Hepatocellular Carcinoma TreatmentAdvanced Functional Materials, 2024
- Cu+/Ca2+ Dual‐Overload Strategy Assisted by Metabolic‐Symbiotic‐Destruction for Tumor Apoptosis and Tumor Immune ActivationAdvanced Functional Materials, 2024
- Synergistic Interaction between Metal Single‐Atoms and Defective WO3−x Nanosheets for Enhanced Sonodynamic Cancer TherapyAdvanced Materials, 2024
- Decomposable Nanoagonists Enable NIR‐Elicited cGAS‐STING Activation for Tandem‐Amplified Photodynamic‐MetalloimmunotherapyAdvanced Materials, 2024
- A Multichannel Metabolic Pathway Interference Strategy for Complete Energy Depletion‐Mediated Cancer TherapyAdvanced Functional Materials, 2024
- Nivolumab for Patients With High-Risk Oral LeukoplakiaJAMA Oncology, 2024
- Ultrathin Clay Nanoparticles‐Mediated Mutual Reinforcement of Ferroptosis and Cancer ImmunotherapyAdvanced Materials, 2023
- Nanoscintillator‐Mediated X‐Ray‐Triggered Boosting Transformation of Fe3+ into Fe2+ for Enhancing Tumor Ferroptosis/ImmunotherapyAdvanced Functional Materials, 2023
- A Strategy of Fenton Reaction Cycloacceleration for High‐Performance Ferroptosis Therapy Initiated by Tumor Microenvironment RemodelingAdvanced Healthcare Materials, 2023
- Reaction Mechanisms in Platinum‐Mediated Electrodynamic TherapyAdvanced Functional Materials, 2023